Ranitidine hydrochloride and Enzyme abnormality - a phase IV clinical study of FDA data

Summary:

Enzyme abnormality is reported only by a few people who take Ranitidine Hydrochloride.

The phase IV clinical study analyzes which people take Ranitidine hydrochloride and have Enzyme abnormality. It is created by eHealthMe based on reports of 66,984 people who have side effects while taking Ranitidine hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 27, 2023

66,984 people reported to have side effects when taking Ranitidine hydrochloride.
Among them, 2 people (0.0%) have Enzyme abnormality.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 67,576 Ranitidine hydrochloride users for its effectiveness, alternative drugs and more.

What is Enzyme abnormality?

Enzyme abnormality is found to be associated with 612 drugs and 308 conditions by eHealthMe.

Number of Ranitidine hydrochloride and Enzyme abnormality reports submitted per year:

Could Ranitidine hydrochloride cause Enzyme abnormality?

Gender of people who have Enzyme abnormality when taking Ranitidine hydrochloride *:

female: 100 %
male: 0.0 %

Age of people who have Enzyme abnormality when taking Ranitidine hydrochloride *:

Common drugs people take besides Ranitidine hydrochloride *:

Metoclopramide: 2 people, 100.00%
Vfend: 1 person, 50.00%
Lorazepam: 1 person, 50.00%
Amphotericin B: 1 person, 50.00%
Buspirone Hydrochloride: 1 person, 50.00%
Cefuroxime Sodium: 1 person, 50.00%
Fentanyl: 1 person, 50.00%
Furosemide: 1 person, 50.00%
Hydroxyzine: 1 person, 50.00%
Isoflurane: 1 person, 50.00%

Common side effects people have besides Enzyme abnormality *:

Thrombocytopenia (decrease of platelets in blood): 1 person, 50.00%
Hypoproteinaemia (too little prolactin circulating in the blood): 1 person, 50.00%
Depressed Level Of Consciousness: 1 person, 50.00%
Blood Amylase Increased: 1 person, 50.00%
Apnea (temporary absence or cessation of breathing): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and have Enzyme abnormality?

Check whether Enzyme abnormality is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Enzyme abnormality treatments and more:

Enzyme abnormality (835 reports)

COVID vaccines that are related to Enzyme abnormality:

All the drugs that are associated with Enzyme abnormality:

Enzyme abnormality (612 drugs)

All the conditions that are associated with Enzyme abnormality:

Enzyme abnormality (308 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride (the active ingredients of Ranitidine hydrochloride) and Ranitidine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.